The Stryker Hip has voluntarily recalled its Rejuvenate and ABG II modular-neck stem replacement hip systems as listed on the FDA. Stryker will also terminate global distribution of these products. Stryker made this voluntarally recall after continued post-market surveillance.[http://www.fda.gov/Safety/Recalls/ucm311043.htm]
The Stryker hip recall was announced because the femoral pieces can corrode, leaching toxic metal ions into the surrounding tissue, bone and/or bloodstream of implant patients. In addition to the metallosis, tissue necrosis and other problems reported by Stryker hip implant recall patients, some studies have indicated that the chromium and cobalt shed from these devices can spread and cause damage to the lymph nodes, spleen, liver and kidneys.
Patients with one of the recalled Stryker hip components may have to undergo painful revision surgery to have the device removed or replaced if their hip implant has failed. Even if you are not experiencing any pain or swelling, you should contact your doctor for a blood test and imaging scans to determine if your hip is functioning properly. According to Stryker, some patients with these components have been found to have high levels of metal ions in their blood, as well as evidence of local tissue reactions, even in the absence of symptoms.
Stryker has promised to pay for tests, revision surgeries and out-of-pocket expenses related to the Rejuvenate and ABG II recall. In fact, it has even hired Broadspire Services, Inc., a third-party claims administrator, to handle these claims. However, Stryker hip implant recall patients may have other damages, including pain and suffering, emotional distress, and loss of quality of life that may not be covered by Stryker through this program. You should talk to attorney before you discuss your claim with anyone from Stryker or Broadspire to be sure you don’t surrender any legal rights you might have for additional compensation.